Molecular Cloning of a Novel Human CC Chemokine Liver and Activation-regulated Chemokine (LARC) Expressed in Liver

Partial overlapping cDNA sequences likely to encode a novel human CC chemokine were identified from the GenBank Expressed Sequence Tag data base. Using these sequences, we isolated full-length cDNA encoding a protein of 96 amino acid residues with 20-28% identity to other CC chemokines. By Northern blot, this chemokine was mainly expressed in liver among various tissues and strongly induced in several human cell lines by phorbol myristate acetate. We thus designated this chemokine as LARC from iver and ctivation-egulated hemokine. We mapped the LARC gene close to the chromosomal marker D2S159 at chromosome 2q33-q37 by somatic cell and radiation hybrid mappings and isolated two yeast artificial chromosome clones containing the LARC gene from this region. To prepare LARC, we subcloned the cDNA into a baculovirus vector and expressed it in insect cells. The secreted protein started at Ala-27 and was significantly chemotactic for lymphocytes. At a concentration of 1 μg/ml, it also showed a weak chemotactic activity for granulocytes. Unlike other CC chemokines, however, LARC was not chemotactic for monocytic THP-1 cells or blood monocytes. LARC tagged with secreted alkaline phosphatase-(His)6 bound specifically to lymphocytes, the binding being competed only by LARC and not by other CC or CXC chemokines. Scatchard analysis revealed a single class of receptors for LARC on lymphocytes with a Kd of 0.4 nM and 2100 sites/cell. Collectively, LARC is a novel CC chemokine, which may represent a new group of CC chemokines localized on chromosome 2.

[1]  M. Wickens,et al.  Role of the conserved AAUAAA sequence: four AAUAAA point mutants prevent messenger RNA 3' end formation. , 1984, Science.

[2]  M. Nakao,et al.  Structures of human genes coding for cytokine LD78 and their expression , 1990, Molecular and cellular biology.

[3]  P. Leder,et al.  The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation , 1995, The Journal of experimental medicine.

[4]  D. Cook.  The role of MIP‐1α in Inflammation and hematopoiesis , 1996, Journal of leukocyte biology.

[5]  G. Shaw,et al.  A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation , 1986, Cell.

[6]  O. Yoshie,et al.  Molecular Cloning of a Novel T Cell-directed CC Chemokine Expressed in Thymus by Signal Sequence Trap Using Epstein-Barr Virus Vector* , 1996, The Journal of Biological Chemistry.

[7]  M. Frohman,et al.  Rapid amplification of complementary DNA ends for generation of full-length complementary DNAs: thermal RACE. , 1993, Methods in enzymology.

[8]  G. Opdenakker,et al.  Human monocyte chemotactic protein-3 (MCP-3): molecular cloning of the cDNA and comparison with other chemokines. , 1993, Biochemical and biophysical research communications.

[9]  T. Schall,et al.  Molecular cloning and functional characterization of human lymphotactin. , 1995, Journal of immunology.

[10]  P. Bray-Ward,et al.  Integration of the cytogenetic, genetic, and physical maps of the human genome by FISH mapping of CEPH YAC clones. , 1996, Genomics.

[11]  E. Appella,et al.  Human monocyte chemoattractant protein‐1 (MCP‐1) Full‐length cDNA cloning, expression in mitogen‐stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE , 1989, FEBS letters.

[12]  P. Leder,et al.  Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia , 1996, Nature Medicine.

[13]  K. Fujimori,et al.  Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers. , 1987, Cancer research.

[14]  M V Olson,et al.  Systematic screening of yeast artificial-chromosome libraries by use of the polymerase chain reaction. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[15]  M. Krangel,et al.  Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. , 1992, Critical reviews in immunology.

[16]  S. Arya,et al.  Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells , 1995, Science.

[17]  M. Boguski,et al.  dbEST — database for “expressed sequence tags” , 1993, Nature Genetics.

[18]  C. J. Beall,et al.  Conversion of monocyte chemoattractant protein-1 into a neutrophil attractant by substitution of two amino acids. , 1992, The Journal of biological chemistry.

[19]  M. Raida,et al.  HCC-1, a novel chemokine from human plasma , 1996, The Journal of experimental medicine.

[20]  G. Opdenakker,et al.  Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family , 1992, The Journal of experimental medicine.

[21]  T. Standiford,et al.  "The good, the bad, and the ugly." The role of chemokines in models of human disease. , 1996, Journal of immunology.

[22]  J. Mermod,et al.  Mutation of Leu25 and Val27 Introduces CC Chemokine Activity into Interleukin-8 (*) , 1995, The Journal of Biological Chemistry.

[23]  Stephen C. Peiper,et al.  Identification of a major co-receptor for primary isolates of HIV-1 , 1996, Nature.

[24]  B. Dewald,et al.  Monocyte chemotactic protein 4 (MCP-4), a novel structural and functional analogue of MCP-3 and eotaxin , 1996, The Journal of experimental medicine.

[25]  P Ramond,et al.  Molecular cloning of the MCP-3 chemokine gene and regulation of its expression. , 1993, European cytokine network.

[26]  J. Inazawa,et al.  Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene. , 1995, Genomics.

[27]  M. Baggiolini,et al.  Deletion of the NH2-terminal residue converts monocyte chemotactic protein 1 from an activator of basophil mediator release to an eosinophil chemoattractant , 1996, The Journal of experimental medicine.

[28]  F. Balkwill.  Cytokines : a practical approach , 1991 .

[29]  Gunnar von Heijne,et al.  Patterns of Amino Acids near Signal‐Sequence Cleavage Sites , 1983 .

[30]  R. F. Smith,et al.  BCM Search Launcher--an integrated interface to molecular biology data base search and analysis services available on the World Wide Web. , 1996, Genome research.

[31]  C. Broder,et al.  CC CKR5: A RANTES, MIP-1α, MIP-1ॆ Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1 , 1996, Science.

[32]  Virginia Litwin,et al.  HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 , 1996, Nature.

[33]  R. de Waal Malefyt,et al.  A novel polypeptide secreted by activated human T lymphocytes. , 1989, Journal of immunology.

[34]  C. Combadière,et al.  Molecular Cloning of Human Eotaxin, an Eosinophil-selective CC Chemokine, and Identification of a Specific Eosinophil Eotaxin Receptor, CC Chemokine Receptor 3 (*) , 1996, The Journal of Biological Chemistry.

[35]  D. Ledbetter,et al.  A YAC contig of the human CC chemokine genes clustered on chromosome 17q11.2. , 1996, Genomics.

[36]  K. Matsushima,et al.  Properties of the novel proinflammatory supergene "intercrine" cytokine family. , 1991, Annual review of immunology.

[37]  G. Opdenakker,et al.  Expression of a human mutant monocyte chemotactic protein 3 in Pichia pastoris and characterization as an MCP-3 receptor antagonist. , 1995, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[38]  O. Yoshie,et al.  Structure and expression of two highly related genes encoding SCM‐1/human lymphotactin , 1996, FEBS letters.

[39]  B. Dewald,et al.  Platelet factor 4 binds to interleukin 8 receptors and activates neutrophils when its N terminus is modified with Glu-Leu-Arg. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[40]  J. Baker,et al.  Scanning mutagenesis of interleukin-8 identifies a cluster of residues required for receptor binding. , 1991, The Journal of biological chemistry.

[41]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[42]  M. Baggiolini,et al.  Structure-activity relationships of interleukin-8 determined using chemically synthesized analogs. Critical role of NH2-terminal residues and evidence for uncoupling of neutrophil chemotaxis, exocytosis, and receptor binding activities. , 1991, The Journal of biological chemistry.

[43]  J. Renauld,et al.  I-309/T cell activation gene-3 chemokine protects murine T cell lymphomas against dexamethasone-induced apoptosis. , 1996, Journal of immunology.

[44]  G. Gyapay,et al.  A radiation hybrid map of the human genome. , 1996, Human molecular genetics.

[45]  M. Yamada,et al.  Cloning and sequencing of the cDNA for human monocyte chemotactic and activating factor (MCAF). , 1989, Biochemical and biophysical research communications.

[46]  O. Yoshie,et al.  Molecular cloning of a novel C or γ type chemokine, SCM‐1 , 1995 .

[47]  W Newman,et al.  Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. , 1996, The Journal of clinical investigation.

[48]  M. Kozak.  An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. , 1987, Nucleic acids research.

[49]  D. Largaespada,et al.  Lymphotactin: a cytokine that represents a new class of chemokine. , 1994, Science.